Targeted DNA sequencing of NF1-mutant, IDH wild-type glioblastomas (n = 186) identified CDKN2A/B homozygous deletion as a poor prognostic marker in NF1-mutant, but not NF1 wild-type, glioblastomas. Here, CDKN2A is linked to glioblastoma.